Applying continual learning strategies for classification of cervical cells
2022
0 views
0 downloads
Advisor: Doç. Dr. Dıonysıs Goularas
Abstract (EN)
Medical imaging plays an essential role in clinical diagnosis and therapy planning. Machine learning is gaining popularity because it captures illness and therapy response characteristics. The continual improvement of image collecting technology and diagnostic methods, the diversity of scanners and developing imaging protocols, and field shifts restrict the usefulness of machine learning as predicted accuracy on new data degrades or models become out-of-date. An example for such shifts is pap smear imaging. This thesis presents applications of continual learning strategies for tackling models' outdating due to the domain shifts in pap smear images. Two popular convolutiunal neural network (CNN) architectures (InceptionV3 and ResNet50), and a custom 2-layer CNN are trained with three pap smear benchmark datasets (Sipakmed, Herlev, and CRIC). Several continual learning strategies are employed when training the models. Finally, the models for each strategy are evaluated, and the comparative results are presented
Author
Gökhan Akgün
How to Cite
Gökhan Akgün (Master Thesis). Applying continual learning strategies for classification of cervical cells, 2022, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)